Adipotide vs Dulaglutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...
Calculate Adipotide dose →Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular risk factors. It is an Fc-fusion protein consisting of two modified GLP-1 molecule...
Calculate Dulaglutide dose →| Parameter | Adipotide | Dulaglutide |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | FDA Approved |
| Half-Life | - | ~5 days |
| Typical Dose | 1 mg/kg body weight | 0.75–4.5 mg |
| Frequency | Daily (research cycles) | Once weekly |
| Route | Subcutaneous | Subcutaneous (weekly) |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.